Ultrapure magnesium alloy with adjustable degradation rate
View Patent ↗An alloy and an implant having a three-dimensional structure based on such alloy. The alloy comprises a monophasic MgZn alloy containing from 2.0 wt. % Zn to 6 wt. % Zn, having less than 0.001 wt. % of one or more other elements with the remainder being Mg. In some embodiments, the alloy is substantially free of microgalvanic elements. In some embodiments, the alloy includes a MgZnCa alloy containing nanosized precipitates being less noble than the Mg matrix alloy and having a Zn content ranging from 3.0 wt. % Zn to 6 wt. % Zn and a calcium content ranging from 0.0005 wt. % to 1.0 wt. %, having less than 0.001 wt. % of one or more other elements with the remainder being Mg. In other embodiments, the alloy includes a MgZnCa alloy containing nanosized precipitates being less noble than the Mg matrix alloy, a plurality of nanosized precipitates being more noble than the Mg matrix and having a Zn content ranging from 3.0 wt. % Zn to 6 wt. % Zn, a calcium content ranging from 0.0005 wt. % to 1.0 wt. %, having less than 0.001 wt. % of one or more other elements with the remainder being Mg.
1. A medical implant comprising:
a MgZnCa alloy containing nanosized precipitates, wherein the nanosized precipitates are less noble than a MgZn alloy, and wherein the MgZnCa alloy has a Zn content ranging from 3.0 wt. % Zn to 6 wt. % Zn and a calcium content ranging from 0.0005 wt. % Ca to 1.0 wt. % Ca, less than 0.001 wt. % of one or more other elements and with the remainder of the alloy being Mg, wherein the Mg has a purity of at least 99.997 wt. %, the Zn has a purity of at least 99.999 wt. %, and the Ca has a purity of at least 99.9 wt. %.
2. The implant according to claim 1 , wherein the MgZnCa alloy contains less than 5 ppm of total other elements.
3. The implant according to claim 1 , wherein the MgZnCa alloy contains less than 2 ppm of total other elements.
4. The implant according to claim 1 , wherein the MgZnCa alloy contains less than 1 ppm of total other elements.
5. The implant according to claim 1 , wherein the MgZnCa alloy contains less than 0.5 ppm of total other elements.
6. The implant according to claim 1 , wherein the other elements comprise one or more of Fe, Cu, Ni, Co, Si, Mn, Al, Zr, and P.
7. The implant according to claim 1 , wherein the MgZnCa alloy contains less than 0.1 ppm Ni.
8. The implant according to claim 1 , wherein the MgZnCa alloy contains less than 0.001 wt. % of rare earth elements.
9. The implant according to claim 8 , wherein the rare earth elements comprise one or more of Sc, Y, the Lanthanide elements having atomic numbers ranging from 57-71, and the Actinide elements having atomic numbers ranging from 89-103.
10. The implant according to claim 1 , further comprising a plurality of nanosized precipitates being more noble than the MgZn alloy, wherein the nanosized precipitates comprise Mn—Zn.
11. The implant according to claim 1 , wherein the MgZnCa alloy has a grain size of less than 10 μm.
12. The implant according to claim 1 , wherein the MgZnCa alloy has a yield strength of at least 200 MPa.
13. The implant according to claim 1 , wherein the MgZnCa alloy has an ultimate tensile strength of at least 250 MPa.
14. The implant according to claim 1 , wherein the MgZnCa alloy has at least 15% elongation at break.
15. A medical implant comprising: a MgZnCa alloy, having a Zn content ranging from 3.0 wt. % Zn to 6 wt. % Zn, the Zn having a purity of at least 99.999 wt. %, a calcium content ranging from 0.0005 wt. % Ca to 1.0 wt. % Ca, the Ca having a purity of at least 99.9 wt. %, less than 0.001 wt. % of one or more other elements located in a secondary phase and with the remainder of the alloy being Mg having a purity of at least 99.997 wt. %, wherein the MgZnCa alloy contains nanosized precipitates being less noble than the Mg remainder.